Update on cell therapy for stroke.

Abstract excerpt

Ischaemic stroke remains a leading cause of death and disability. Current stroke treatment options aim to minimise the damage from a pending stroke during the acute stroke period using intravenous thrombolytics and endovascular thrombectomy; however, there are no currently approved treatment options for reversing neurological damage once a stroke is completed. Preclinical studies suggest that cell therapy may be...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disability Evaluation
• Share to Ischemic Stroke
• Share to Neural Stem Cells